Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies

The Journal of Pathology(2022)10.1002/path.5887Source: DataRank Database

Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies is a research paper published in The Journal of Pathology (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)Impact (FWCI 3.81)OA: hybridTopics (68)Linked Datasets (6)DataCite Reuse (6)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (18)

Davide Prandi ORCID,Arshi Arora ORCID,Daniel H. Hovelson ORCID,Andrea Sboner ORCID,Antonio Rodrı́guez ORCID

Live enrichment

PubMed:35220606 PMC:PMC9311708 OpenAlex:https://openalex.org/W4214709940

National Science Foundation of Sri Lanka

Grant: R37 CA241486

National Science Foundation of Sri Lanka

Grant: R01 CA125612

H2020 European Research Council

Grant: 648670

Synthetic Lethal Phenotype Identification through Cancer Evolution Analysis

National Institutes of Health

Grant: P50‐CA211024

NCI NIH HHS

Grant: P50 CA097186

NCI NIH HHS

Grant: P50 CA211024

NCI NIH HHS

Grant: P30 CA008748

National Institutes of Health

Grant: 5R01CA125612-04

Towards Understanding Prostate Cancer Heterogeneity

National Institutes of Health

Grant: 1P50CA211024-01A1

Weill Cornell Medicine (WCM) SPORE in Prostate Cancer

National Institutes of Health

Grant: 5P50CA097186-13

Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment

National Institutes of Health

Grant: 5R37CA241486-03

Molecular mechanisms underlying lineage plasticity in prostate cancer

Fondation pour la Recherche Nuovo-Soldati

FWCI

3.81

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/path.5887

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/path.5887

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5887

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/path.5887

publisherhttps://pathsocjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/path.5887

Fields of Study

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentCancer Genomics and Diagnostics0301 basic medicine03 medical and health sciences0303 health sciencesGenomicsHumansMaleNuclear ProteinsPhylogenyPilot ProjectsProstatectomyProstatic NeoplasmsProstatic Neoplasms, Castration-ResistantRepressor Proteins

MeSH Terms

HumansMaleNuclear ProteinsPhylogenyPilot ProjectsProstatectomyProstatic NeoplasmsRepressor ProteinsGenomicsProstatic Neoplasms, Castration-Resistant

Keywords

Prostate cancerProstatectomyProstatePathologyPrimary tumorExome sequencingAmpliconBiologyTumour heterogeneityCancerTMPRSS2Localized diseaseMedicineOncologyDiseaseInternal medicineMetastasisMutationGeneGeneticsPolymerase chain reactionHeterogeneityGenomicsMultifocalTranscriptomicsCrpcCastration-resistantNepcMale610Pilot ProjectsCRPC; NEPC; castration-resistant; genomics; heterogeneity; metastasis; multifocal; pathology; prostate cancer; transcriptomicsgenomicHealth SciencesHumansPhylogenyNuclear ProteinsProstatic NeoplasmsOriginal ArticlesRepressor ProteinsProstatic Neoplasms, Castration-Resistantmetastasi

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 1 of Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

10.6084/m9.figshare.24303277.v1figshare

Additional file 1 of Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

10.6084/m9.figshare.24303277figshare

Additional file 2 of Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

10.6084/m9.figshare.24303456.v1figshare

Additional file 3 of Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

10.6084/m9.figshare.26626357.v1figshare

Additional file 2 of Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

10.6084/m9.figshare.24303456figshare

Additional file 3 of Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine

10.6084/m9.figshare.26626357figshare